Antibody-drug conjugates in breast cancer treatment: resistance mechanisms and the role of therapeutic sequencing
{{output}}
Antibody-drug conjugates (ADCs) are a transformative approach in breast cancer therapy, offering targeted treatment with reduced toxicity by selectively delivering cytotoxic agents to cancer cells. While ADCs like trastuzumab emtansine (T-DM1), trastuzumab der... ...
